Last reviewed · How we verify
Gatorade/Miralax
Miralax (polyethylene glycol) draws water into the intestinal lumen to soften stool and promote bowel movements, while Gatorade provides electrolyte and fluid replacement.
Miralax (polyethylene glycol) draws water into the intestinal lumen to soften stool and promote bowel movements, while Gatorade provides electrolyte and fluid replacement. Used for Bowel preparation prior to colonoscopy or other gastrointestinal procedures, Constipation relief.
At a glance
| Generic name | Gatorade/Miralax |
|---|---|
| Sponsor | Gastroenterology Services, Ltd. |
| Drug class | Osmotic laxative |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Mechanism of action
Polyethylene glycol is an osmotic laxative that works by increasing the osmotic pressure in the colon, which pulls water into the bowel and softens stool to facilitate evacuation. This combination is commonly used for bowel preparation prior to colonoscopy or other gastrointestinal procedures. The Gatorade component helps maintain electrolyte balance and hydration during the bowel cleansing process.
Approved indications
- Bowel preparation prior to colonoscopy or other gastrointestinal procedures
- Constipation relief
Common side effects
- Nausea
- Abdominal bloating
- Abdominal cramping
- Vomiting
- Anal irritation
Key clinical trials
- Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens (PHASE4)
- Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease (PHASE2)
- Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep (PHASE4)
- Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease (PHASE2)
- Safety and Efficacy of High Dose Bowel Preparation Solutions for Patients With Difficult To Clean Colons For Colonoscopy
- Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy (PHASE4)
- A Comparison of 5 Low Volume Bowel Preparations (PHASE4)
- Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gatorade/Miralax CI brief — competitive landscape report
- Gatorade/Miralax updates RSS · CI watch RSS
- Gastroenterology Services, Ltd. portfolio CI